Drug Based Side Effects Treatment Market on an Accelerated Innovation Spree

  • 30 Apr 2019

High dependency on NSAIDS pain management drugs for pain relief in patients with chronic conditions like cancer, seizures and chronic, increasing dependency on nutritional supplements, rising cases of mental health and related depression treatments, inflammatory conditions in arthritis patients is a burgeoning issue due to related drug-based side effects. Besides the availability of novel OTC drugs that are used with little or no knowledge of how they work is resulting in undesired side effects. An upsurge in the addictive behaviour that including smoking along with alcohol consumption amongst a huge population result in rehabilitation treatments with newer drugs. Also, certain surgical procedures or alternative therapies can adversely affect patients depending on age, gender and disease type. All such elements and known risks associated with legally prescribed drugs potentially call for adverse effects like nausea, drowsiness, dry mouth, birth defects, even death and complications that need hospitalization. Thus drug-based side effects treatment becomes imperative with the help of skilled medical practitioners.


Hypersensitivity to antidepressants, allergic reactions to novel drugs and food products coupled with stringent government norms are fuelling the single-digit growth of the drug-based side effects treatment. Drug-based side effects treatment market is estimated to expand robustly during the forecast period of 2019-2026.


Global Drug-Based Side Effects Treatment Market Competitors Insight

A number of side effect cases reported under the MedWatch program run by the Food and Drugs Association (FDA) rise drastically, the innovation spree holds a potential competitive edge amongst the prominent market players. Drug-Based side effects treatments for a drug-drug interaction, drug-food interactions, drug-herb interactions and OTC preparations are major applicants for advanced solutions. Also, infant -friendly drug-based side effects treatments and arthritis/cancer treatment side effects on blood components are projected to be unique market differentiators that market players can count on.
Market player includes Pfizer Inc, Johnson &Johnson, Novartis AG, Teva Pharmaceuticals, Sanofi S.A.

 

Global Drug-Based Side Effects Treatment Market, by Drug Type

•    Antidepressant
•    Stimulants
•    NSAIDS
•    Anti-emetics
•    Nutrition Supplements
•    Others    
With the rise in treatment-resistant depression(TRD) and addictive behaviour rehabilitation treatments becoming more prevalent the use of antidepressant, NSAIDS, stimulants become ubiquitous. So are the side effects that need to be addressed. Thus antidepressant segment is expected to grow at a lucrative CAGR for the next eight years or so.

Global Drug-Based Side Effects Treatment Market, by Distribution Channel
•    Hospital Pharmacies
•    Retail Pharmacies
•    E-Commerce Channels


Global Drug-Based Side Effects Treatment Market, by Region
•    North America
•    Latin America
•    Europe
•    Asia Pacific
•    Rest of the World
Due to existing high market penetration, the North America region leads the global drug-based side effects treatment market in terms of revenue. The increasing R&D investments and high-tech healthcare infrastructure are expected to facilitate further growth in CAGR of North America and Europe region around the forecast duration. APAC region presents tremendous progressive opportunities with the rising awareness towards treating drug side-effects. The rest of the world is estimated to demonstrate considerable CAGR during the next few years.


Competitive Landscape:  

•    Tier 1 players- established companies in the market with a major    market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

 

FutureWise Key Takeaways 

•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

 

Objectives of the Study: 
•    To provide with an exhaustive analysis on the global drug based side effects treatment market on the basis of drug type, distribution channel, and region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

 

Get unlimited analyst support and customise this study further to your requirements, contact [email protected]